NASDAQ: EIDX - Eidos Therapeutics, Inc.
Yield per half year: +178.07%
Dividend yield: 0.00%
Sector: Healthcare
Reporting Eidos Therapeutics, Inc.
Capitalization
IFRS
Annual
Quarterly
Balance sheet
IFRS
Annual
Quarterly
Share
IFRS
Annual
Quarterly
Efficiency
IFRS
Annual
Quarterly
Coefficients
IFRS
Annual
Quarterly
Dividends
IFRS
Annual
2020 | LTM | Industry average | 5 year average | CAGR 5 | |
---|---|---|---|---|---|
ΠΠΈΠ²ΠΈΠ΄Π΅Π½Π΄Ρ / ΠΏΡΠΈΠ±ΡΠ»Ρ, %
|
0 | 0 | 40.48 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription